The efficacy of augment of D-Cycloserine and cognitive-behavioral therapy on symptoms improvement in the adolescents with one type of anxiety disorders: A double-blind randomized controlled trial

Isfahan University of Medical Sciences, School of Medicine, Vice Chancellor for Research0 个研究点目标入组 36 人开始时间: 待定最近更新: 2018年2月22日

适应症

试验速览

暂无简介。

•1- The adolescents with the age of 12-20 years with anxiety disorders needing therapeutic interventions and receiving anti-anxiety treatment according to the children psychiatrist, 2- Lack of any background pertaining to serious psychological or physical problems, mood disorders, psychosis or delusional disorders and drug dependency,3- Lack of any changes in anti-anxiety drugs or any changes in their doses during 4 weeks before the study,4- Lack of learning disorders based on mental check-up,5- lack of any background associated with seizure and severe depression coupled with the thoughts of suicide, 6- The IQ equal or higher than 80 (it was measured applying Raven Test and by an independent psychiatrist) are of inclusion criteria.

•1-The patients who were absent for more than one session and those whose parents or themselves did not intend to continue the treatment.

发起方

Isfahan University of Medical Sciences, School of Medicine, Vice Chancellor for Research